It is an exciting time in RNA research as we are seeing cutting-edge therapies emerging all the time. Here we are taking a quick look at some of…

  Since their initial explosion onto the market, there is a growing pipeline demonstrating the promise of aptamer therapeutics across…

Affinity binders are the workhorses of assays and methods across the life sciences. From biologics to bioprocessing ligands and research reagents, the requirements for affinity binders vary according to…

Dr Daniel Wiseman is a Senior Clinical Lecturer at the University of Manchester, and a Consultant Haematologist at the Christie NHS Foundation. He is exploring Optimer® binders as…